Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cognitive problems may be present before chemotherapy in women with breast cancer

SABCS 2012

Published: 12 Dec 2012

Views: 3245

Rating:

Save

Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA

At a press conference at SABCS 2012, Prof Cimprich presents data on a study looking at women undergoing chemotherapy who experience cognitive problems, commonly referred to as “chemo brain,” displayed alterations in neurocognitive responses prior to undergoing treatment.

Related Videos

Breast cancer survivorship

Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg

Breast cancer survivorship ( Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg )

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy

Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy ( Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )

Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer

Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy

Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )

Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC

Dr Alberto Servetto - University of Naples Federico II, Naples, Italy

Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC ( Dr Alberto Servetto - University of Naples Federico II, Naples, Italy )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

The advancements in radiotherapy for breast cancer patients

Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia

The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )

Loco-regional management after neoadjuvant chemotherapy

Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA

Loco-regional management after neoadjuvant chemotherapy ( Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA )

Cancer pain management

Prof Ebtesam Ahmed - St John's University New York, New York City, USA

Cancer pain management ( Prof Ebtesam Ahmed - St John's University New York, New York City, USA )

Management of HER2 positive metastatic breast cancer treatment algorithm

Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA

Management of HER2 positive metastatic breast cancer treatment algorithm ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )

More from ecancer